Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Who Manages Index Funds involves the fund sponsor, index provider, and governance teams ensuring tracking accuracy and compliance. Grasp their roles for smarter choices.
12,805 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Tech-led selling pushed the Nasdaq Composite lower as investors weigh higher yields and fresh data. The broader marke...
crude rockets past $100 as Iran tensions persist, traders fear longer supply constraints and higher gasoline costs ac...
Retirees chasing EDIV’s yield are flocking to emerging markets for higher income, but the strategy embeds currency ri...
Trump says the conflict is complete, but Wall Street expects the Fed to stay hawkish. Oil spikes, inflation worries, ...
A well-known oil stock is catching investor attention as demand for energy climbs. This guide breaks down why the sto...
With a 15-day deadline to resolve Iran tensions, U.S. markets brace for a volatile April as traders weigh oil, stocks...
Dreaming of a portfolio that compounds for decades? This article lays out three growth stocks hold forever that pass ...
A new Stanford study finds tax refunds do little to blunt the impact of higher gasoline prices on American households...
After a sharp drop in Robinhood stock, investors wonder what comes next. This article breaks down scenarios, real-wor...
Forecasts point to a higher 2027 social security cola as energy prices climb, potentially boosting benefits but signa...
Bitcoin holds near $71,000 as geopolitical risk cools, yet a raft of macro factors and an ETF decision window keep th...